SAGE THERAPEUTICS Trademark

Trademark Overview

On Friday, August 1, 2014, a trademark application was filed for SAGE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SAGE THERAPEUTICS trademark a serial number of 86355377. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, December 23, 2022. This trademark is owned by Sage Therapeutics, Inc.. The SAGE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services, namely, research and development of pharmaceuticals to treat central nervous system disorders
sage therapeutics

General Information

Serial Number86355377
Word MarkSAGE THERAPEUTICS
Filing DateFriday, August 1, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, December 23, 2022
Registration Number4879416
Registration DateTuesday, January 5, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 14, 2015

Trademark Statements

Description of MarkThe mark consists of the words "SAGE THERAPUTICS", to the left of which appears an image of a solid circle enclosed in a larger incomplete circle.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services, namely, research and development of pharmaceuticals to treat central nervous system disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 11, 2014
Primary Code042
First Use Anywhere DateFriday, September 30, 2011
First Use In Commerce DateFriday, September 30, 2011

Trademark Owner History

Party NameSage Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSage Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSage Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, August 5, 2014NEW APPLICATION ENTERED
Monday, August 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 12, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, November 15, 2014ASSIGNED TO EXAMINER
Saturday, November 22, 2014NON-FINAL ACTION WRITTEN
Saturday, November 22, 2014NON-FINAL ACTION E-MAILED
Saturday, November 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 7, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 7, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2015ASSIGNED TO EXAMINER
Wednesday, May 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 10, 2015ASSIGNED TO LIE
Wednesday, June 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 24, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 14, 2015PUBLISHED FOR OPPOSITION
Tuesday, July 14, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 13, 2015EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, November 27, 2015EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 5, 2016REGISTERED-PRINCIPAL REGISTER
Friday, April 27, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 27, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 4, 2020COUNTERCLAIM OPP. NO. 999999
Tuesday, January 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 1, 2022TEAS SECTION 8 RECEIVED
Friday, December 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 23, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, December 23, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, July 22, 2024TEAS SECTION 15 RECEIVED
Friday, November 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 1, 2024REGISTERED - SEC. 15 ACKNOWLEDGED
Friday, November 1, 2024SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Sunday, January 5, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

therapeutics sage research development nervous system disorders central pharmaceuticals services namely pharmaceutical